Recent Finacing
Recent Raise
Bloom Science develops microbiome-based therapeutics for neurological diseases using its IrisRx reverse-translation platform to identify and engineer microbial consortia targeting the gut-immune-brain axis, advancing programs for drug-resistant epilepsy and ALS.
